BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND BCL3, P20749, 602, ENSG00000069399, D19S37, BCL4 AND Treatment
35 results:

  • 1. Exploring the role of GHRH antagonist MIA-602 in overcoming Doxorubicin-resistance in acute myeloid leukemia.
    Gaumond SI; Abdin R; Costoya J; Schally AV; Jimenez JJ
    Oncotarget; 2024 Apr; 15():248-254. PubMed ID: 38588464
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Clinical characteristics of 11 patients with chronic lymphocytic leukemia with t (14;19) (q32;q13)].
    Cui CH; Chang YN; Zhou J; Li CW; Wang HJ; Sun Q; Jia YJ; Li QH; Wang TY; Qiu LG; Yi SH
    Zhonghua Xue Ye Xue Za Zhi; 2023 May; 44(5):418-423. PubMed ID: 37550193
    [No Abstract]    [Full Text] [Related]  

  • 3. [Clinical analysis of 20 cases of small B lymphocyte proliferative disease with t (14;19) (q32;q13)].
    Yang H; Guo R; Shi Y; Qiao C; Wu YJ; Fan L; Xu W; Miao KR; Li JY; Qiu HR
    Zhonghua Xue Ye Xue Za Zhi; 2022 Aug; 43(8):674-679. PubMed ID: 36709153
    [No Abstract]    [Full Text] [Related]  

  • 4. Features of Epstein-Barr Virus and Cytomegalovirus Reactivation in Acute leukemia Patients After Haplo-HCT With Myeloablative ATG-Containing Conditioning Regimen.
    Ru Y; Zhu J; Song T; Ding Y; Zhu Z; Fan Y; Xu Y; Sun A; Qiu H; Jin Z; Tang X; Han Y; Fu C; Chen S; Ma X; Chen F; Chen J; Wu D
    Front Cell Infect Microbiol; 2022; 12():865170. PubMed ID: 35651756
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Evaluation of arsenic species in leukocytes and granulocytes of acute promyelocytic leukemia patients treated with arsenic trioxide.
    Wang X; Qian Z; Li H; Chen H; Lin L; Guo M; Hai X
    J Pharm Biomed Anal; 2021 Sep; 203():114201. PubMed ID: 34130006
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Safety and efficacy profile of mogamulizumab (Poteligeo) in the treatment of cancers: an update evidence from 14 studies.
    Zhang T; Sun J; Li J; Zhao Y; Zhang T; Yang R; Ma X
    BMC Cancer; 2021 May; 21(1):618. PubMed ID: 34039310
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. treatment outcomes in children with Acute lymphoblastic leukemia with versus without coexisting Down's syndrome: A systematic review and meta-analysis.
    Liao W; Liu Y
    Medicine (Baltimore); 2020 Jul; 99(29):e21015. PubMed ID: 32702842
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The role of B-Cell Lymphoma-3 (BCL-3) in enabling the hallmarks of cancer: implications for the treatment of colorectal carcinogenesis.
    Legge DN; Chambers AC; Parker CT; Timms P; Collard TJ; Williams AC
    Carcinogenesis; 2020 May; 41(3):249-256. PubMed ID: 31930327
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The DOT1L inhibitor Pinometostat decreases the host-response against infections: Considerations about its use in human therapy.
    Marcos-Villar L; Nieto A
    Sci Rep; 2019 Nov; 9(1):16862. PubMed ID: 31727944
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Virus reactivation and low dose of CD34+ cell, rather than haploidentical transplantation, were associated with secondary poor graft function within the first 100 days after allogeneic stem cell transplantation.
    Sun YQ; Wang Y; Zhang XH; Xu LP; Liu KY; Yan CH; Liu ZY; Huang XJ
    Ann Hematol; 2019 Aug; 98(8):1877-1883. PubMed ID: 31144019
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. bcl3 Expression Is a Potential Prognostic and Predictive Biomarker in Acute Myeloid leukemia of FAB Subtype M2.
    Niu Y; Yang X; Chen Y; Zhang L; Jin X; Tang Y; Li L; Yu L; Guo Y; Wang H
    Pathol Oncol Res; 2019 Apr; 25(2):541-548. PubMed ID: 30357752
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Molecular Markers and Prognosis of Myelofibrosis in the Genomic Era: A Meta-analysis.
    Lee YC; Hsieh CC; Lee YL; Li CY
    Clin Lymphoma Myeloma Leuk; 2018 Sep; 18(9):558-568. PubMed ID: 29970342
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A new approach to the treatment of acute myeloid leukaemia targeting the receptor for growth hormone-releasing hormone.
    Jimenez JJ; DelCanto GM; Popovics P; Perez A; Vila Granda A; Vidaurre I; Cai RZ; Rick FG; Swords RT; Schally AV
    Br J Haematol; 2018 May; 181(4):476-485. PubMed ID: 29663325
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Hepatic B cell leukemia-3 promotes hepatic steatosis and inflammation through insulin-sensitive metabolic transcription factors.
    Gehrke N; Wörns MA; Huber Y; Hess M; Straub BK; Hövelmeyer N; Waisman A; Kim YO; Schuppan D; Galle PR; Schattenberg JM
    J Hepatol; 2016 Dec; 65(6):1188-1197. PubMed ID: 27405060
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Mapping the Interaction of B Cell leukemia 3 (BCL-3) and Nuclear Factor κB (NF-κB) p50 Identifies a BCL-3-mimetic Anti-inflammatory Peptide.
    Collins PE; Grassia G; Colleran A; Kiely PA; Ialenti A; Maffia P; Carmody RJ
    J Biol Chem; 2015 Jun; 290(25):15687-15696. PubMed ID: 25922067
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Results of a trial of PET-directed therapy for early-stage Hodgkin's lymphoma.
    Radford J; Illidge T; Counsell N; Hancock B; Pettengell R; Johnson P; Wimperis J; Culligan D; Popova B; Smith P; McMillan A; Brownell A; Kruger A; Lister A; Hoskin P; O'Doherty M; Barrington S
    N Engl J Med; 2015 Apr; 372(17):1598-607. PubMed ID: 25901426
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Allogeneic stem-cell transplantation in adults 1985-2012: results and development].
    Husøy MA; Brinch L; Tjønnfjord GE; Gedde-Dahl T; Heldal D; Holme PA; Dybedal I; Kolstad A; Akkök ÇA; Rollag H; Gaustad P; Bergan S; Egeland T; Josefsen D; Kvalheim G; Fløisand Y
    Tidsskr Nor Laegeforen; 2014 Sep; 134(16):1569-75. PubMed ID: 25178233
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Acquisition of t(11;14) in a patient with chronic lymphocytic leukemia carrying both t(14;19)(q32;q13.1) and +12.
    Nishida Y; Takeuchi K; Tsuda K; Ugai T; Sugihara H; Yamakura M; Takeuchi M; Matsue K
    Eur J Haematol; 2013 Aug; 91(2):179-82. PubMed ID: 23581835
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Concurrent rearrangements of BCL2, bcl3, and BCL11A genes in atypical chronic lymphocytic leukemia.
    Podgornik H; Pretnar J; Skopec B; Andoljšek D; Černelč P
    Hematology; 2014 Jan; 19(1):45-8. PubMed ID: 23432949
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Expression of Id proteins is regulated by the Bcl-3 proto-oncogene in prostate cancer.
    Ahlqvist K; Saamarthy K; Syed Khaja AS; Bjartell A; Massoumi R
    Oncogene; 2013 Mar; 32(12):1601-8. PubMed ID: 22580608
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.